CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder?

European Neuropsychopharmacology

Volumn 27, Issue 4, 2017, Pages 360-371

  Schartner, Christoph ^a   Ziegler, Christiane ^a   Schiele, Miriam A ^a   Kollert, Leonie ^a   Weber, Heike ^a   Zwanzger, Peter ^a,b   Arolt, Volker ^a   Pauli, Paul ^a   Deckert, Jürgen ^a   Reif, Andreas ^a   Domschke, Katharina ^a  

^a NONE   (Germany)

^b Kbo Inn Salzach Hospital Wasserburg Am Inn   (Germany)

Author keywords

Beck Anxiety Inventory; Corticotropin releasing hormone receptor 1; Epigenetics; HPA axis; Methylation; Panic disorder

Indexed keywords

AGOMELATINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FLUSPIRILENE; HISTONE H4 TRANSCRIPTION FACTOR; HYPERMETHYLATED IN CANCER 2 PROTEIN; MIRTAZAPINE; NOTOCHORD HOMEOBOX PROTEIN; NUCLEAR FACTOR I X PROTEIN; NUCLEAR RESPIRATORY FACTOR 1; OPIPRAMOL; QUETIAPINE; RENILLA LUCIFERIN 2 MONOOXYGENASE; SEROTONIN UPTAKE INHIBITOR; TEA DOMAIN FAMILY MEMBER 1 PROTEIN; TEA DOMAIN FAMILY MEMBER 3 PROTEIN; TEA DOMAIN FAMILY MEMBER 4 PROTEIN; THAP DOMAIN CONTAINING 1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2 ALPHA; TRANSCRIPTION FACTOR AP 2 BETA; TRANSCRIPTION FACTOR AP 2 GAMMA; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRIMIPRAMINE; UNCLASSIFIED DRUG; VALPROIC ACID; VENLAFAXINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ADULT; ARTICLE; BECK ANXIETY INVENTORY; CASE CONTROL STUDY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; PANIC; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOPHARMACOTHERAPY; REPORTER GENE; UPREGULATION; CHI SQUARE DISTRIBUTION; COMPUTER SIMULATION; GENETIC EPIGENESIS; GENETICS; GENOTYPE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; CHI-SQUARE DISTRIBUTION; COMPUTER SIMULATION; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; YOUNG ADULT;

EID: 85013677222     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2017.01.005     Document Type: Article

References (72)

1. Aguilera, G., Nikodemova, M., Wynn, P.C., Catt, K.J., Corticotropin releasing hormone receptors: two decades later. Peptides 25 (2004), 319–329, 10.1016/j.peptides.2004.02.002.
2. Alasaari, J.S., Lagus, M., Ollila, H.M., Toivola, A., Kivimäki, M., Vahtera, J., Kronholm, E., Härmä, M., Puttonen, S., Paunio, T., Environmental stress affects DNA methylation of a CpG rich promoter region of serotonin transporter gene in a nurse cohort. PLoS One, 7, 2012, e45813, 10.1371/journal.pone.0045813.
3. Amstadter, A.B., Nugent, N.R., Yang, B.-Z., Miller, A., Siburian, R., Moorjani, P., Haddad, S., Basu, A., Fagerness, J., Saxe, G., Smoller, J.W., Koenen, K.C., Corticotrophin-releasing hormone type 1 receptor gene (CRHR1) variants predict posttraumatic stress disorder onset and course in pediatric injury patients. Dis. Markers 30 (2011), 89–99, 10.3233/DMA-2011-0761.
4. Binder, E.B., Nemeroff, C.B., The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol. Psychiatry 15 (2010), 574–588, 10.1038/mp.2009.141.
5. Boscarino, J.A., Erlich, P.M., Hoffman, S.N., Zhang, X., Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment. Neuropsychiatr. Dis. Treat. 8 (2012), 131–139, 10.2147/NDT.S29508.
6. Cheng, Y.-H., Handwerger, S., AP-2α modulates human corticotropin-releasing hormone gene expression in the placenta by direct protein–protein interaction. Mol. Cell. Endocrinol. 191 (2002), 127–136, 10.1016/S0303-7207(02)00081-3.
7. Cox, B.J., Cohen, E., Direnfeld, D.M., Swinson, R.P., Does the Beck Anxiety Inventory measure anything beyond panic attack symptoms?. Behav. Res. Ther. 34 (1996), 949–954 (discussion 955–961).
8. Creamer, M., Foran, J., Bell, R., The Beck Anxiety Inventory in a non-clinical sample. Behav. Res. Ther. 33 (1995), 477–485, 10.1016/0005-7967(94)00082-U.
9. Damberg, M., Berggård, C., Mattila-Evenden, M., Rylander, G., Forslund, K., Garpenstrand, H., Bergman, H., Gustavsson, J.P., Jönsson, E.G., Transcription factor AP-2beta genotype associated with anxiety-related personality traits in women. A replication study. Neuropsychobiology 48 (2003), 169–175 (doi:74633).
10. Damberg, M., Ekblom, J., Oreland, L., Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2. Life Sci. 68 (2000), 669–678, 10.1016/S0024-3205(00)00969-3.
11. Davies, M.N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R.A., Milosavljevic, A., Troakes, C., Al-Sarraj, S., Dobson, R., Schalkwyk, L.C., Mill, J., Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol., 13, 2012, R43, 10.1186/gb-2012-13-6-r43.
12. Demers, C.H., Conley, E.D., Bogdan, R., Hariri, A.R., Interactions between anandamide & corticotropin-releasing hormone signaling modulate human amygdala function & risk for anxiety disorders: an imaging genetics strategy for modeling molecular interactions. Biol. Psychiatry, 2016, 10.1016/j.biopsych.2015.12.021.
13. Domschke, K., Tidow, N., Kuithan, H., Schwarte, K., Klauke, B., Ambrée, O., Reif, A., Schmidt, H., Arolt, V., Kersting, A., Zwanzger, P., Deckert, J., Monoamine oxidase A gene DNA hypomethylation – a risk factor for panic disorder?. Int. J. Neuropsychopharmacol. 15 (2012), 1217–1228, 10.1017/S146114571200020X.
14. Domschke, K., Tidow, N., Schrempf, M., Schwarte, K., Klauke, B., Reif, A., Kersting, A., Arolt, V., Zwanzger, P., Deckert, J., Epigenetic signature of panic disorder: a role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation?. Prog. Neuropsychopharmacol. Biol. Psychiatry 46 (2013), 189–196, 10.1016/j.pnpbp.2013.07.014.
15. Domschke, K., Tidow, N., Schwarte, K., Deckert, J., Lesch, K.-P., Arolt, V., Zwanzger, P., Baune, B.T., Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response. Int. J. Neuropsychopharmacol. 17 (2014), 1167–1176, 10.1017/S146114571400039X.
16. Domschke, K., Tidow, N., Schwarte, K., Ziegler, C., Lesch, K.-P., Deckert, J., Arolt, V., Zwanzger, P., Baune, B.T., Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response. J. Neural Transm. 122 (2015), 99–108, 10.1007/s00702-014-1227-x.
17. Dong, X., Stothard, P., Forsythe, I.J., Wishart, D.S., PlasMapper: a web server for drawing and auto-annotating plasmid maps. Nucleic Acids Res. 32 (2004), W660–W664, 10.1093/nar/gkh410.
18. Ewald, E.R., Wand, G.S., Seifuddin, F., Yang, X., Tamashiro, K.L., Potash, J.B., Zandi, P., Lee, R.S., Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure. Psychoneuroendocrinology 44 (2014), 112–122, 10.1016/j.psyneuen.2014.03.003.
19. Hamm, A.O., Richter, J., Pané-Farré, C.A., When the threat comes from inside the body: a neuroscience based learning perspective of the etiology of panic disorder. Restor. Neurol. Neurosci. 32 (2014), 79–93, 10.3233/RNN-139011.
20. Heberlein, A., Muschler, M., Frieling, H., Behr, M., Eberlein, C., Wilhelm, J., Gröschl, M., Kornhuber, J., Bleich, S., Hillemacher, T., Epigenetic down regulation of nerve growth factor during alcohol withdrawal. Addict. Biol. 18 (2013), 508–510, 10.1111/j.1369-1600.2010.00307.x.
21. Heitland, I., Groenink, L., Bijlsma, E.Y., Oosting, R.S., Baas, J.M.P., Human fear acquisition deficits in relation to genetic variants of the corticotropin releasing hormone receptor 1 and the serotonin transporter. PLoS One, 8, 2013, e63772, 10.1371/journal.pone.0063772.
22. Heitland, I., Groenink, L., van Gool, J.M., Domschke, K., Reif, A., Baas, J.M.P., Human fear acquisition deficits in relation to genetic variants of the corticotropin releasing hormone receptor 1 and the serotonin transporter - revisited. Genes. Brain Behav, 2015, 10.1111/gbb.12276.
23. Hillemacher, T., Frieling, H., Hartl, T., Wilhelm, J., Kornhuber, J., Bleich, S., Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving. J. Psychiatr. Res. 43 (2009), 388–392, 10.1016/j.jpsychires.2008.04.006.
24. Hodges, L.M., Weissman, M.M., Haghighi, F., Costa, R., Bravo, O., Evgrafov, O., Knowles, J.A., Fyer, A.J., Hamilton, S.P., Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 150B (2009), 65–73, 10.1002/ajmg.b.30773.
25. Holsboer, F., The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 33 (1999), 181–214.
26. Hubert, M.A., Sherritt, S.L., Bachurski, C.J., Handwerger, S., Involvement of transcription factor NR2F2 in human trophoblast differentiation. PLoS One, 5, 2010, e9417, 10.1371/journal.pone.0009417.
27. Ishitobi, Y., Nakayama, S., Yamaguchi, K., Kanehisa, M., Higuma, H., Maruyama, Y., Ninomiya, T., Okamoto, S., Tanaka, Y., Tsuru, J., Hanada, H., Isogawa, K., Akiyoshi, J., Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 159B (2012), 429–436, 10.1002/ajmg.b.32046.
28. Jaenisch, R., Bird, A., Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33:Suppl (2003), 245–254, 10.1038/ng1089.
29. Keck, M.E., Kern, N., Erhardt, A., Unschuld, P.G., Ising, M., Salyakina, D., Müller, M.B., Knorr, C.C., Lieb, R., Hohoff, C., Krakowitzky, P., Maier, W., Bandelow, B., Fritze, J., Deckert, J., Holsboer, F., Müller-Myhsok, B., Binder, E.B., Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B (2008), 1196–1204, 10.1002/ajmg.b.30750.
30. Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M., Haussler, D., The Human Genome Browser at UCSC. Genome Res 12 (2002), 996–1006, 10.1101/gr.229102.
31. Klug, M., Rehli, M., Functional Analysis of Promoter CPG-Methylation using a CpG-Free Luciferase Reporter Vector. Epigenetics 1 (2014), 127–130, 10.4161/epi.1.3.3327.
32. Lewin, J., Schmitt, A.O., Adorjan, P., Hildmann, T., Piepenbrock, C., Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 20 (2004), 3005–3012, 10.1093/bioinformatics/bth346.
33. Leyfer, O.T., Ruberg, J.L., Woodruff-Borden, J., Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J. Anxiety Disord. 20 (2006), 444–458, 10.1016/j.janxdis.2005.05.004.
34. Markovic, D., Bari, M.F., Lu, B., Vatish, M., Grammatopoulos, D.K., Corticotropin-releasing hormone interacts with interleukin-1β to regulate prostaglandin H synthase-2 expression in human myometrium during pregnancy and labor. J. Clin. Endocrinol. Metab. 98 (2013), 2864–2875, 10.1210/jc.2013-1094.
35. Massart, R., Dymov, S., Millecamps, M., Suderman, M., Gregoire, S., Koenigs, K., Alvarado, S., Tajerian, M., Stone, L.S., Szyf, M., Overlapping signatures of chronic pain in the DNA methylation landscape of prefrontal cortex and peripheral T cells. Sci. Rep., 6, 2016, 19615, 10.1038/srep19615.
36. Mathelier, A., Fornes, O., Arenillas, D.J., Chen, C.-Y., Denay, G., Lee, J., Shi, W., Shyr, C., Tan, G., Worsley-Hunt, R., Zhang, A.W., Parcy, F., Lenhard, B., Sandelin, A., Wasserman, W.W., JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles. Nucleic Acids Res., 2015, 10.1093/nar/gkv1176.
37. Mitchell, P.J., Timmons, P.M., Hébert, J.M., Rigby, P.W., Tjian, R., Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5 (1991), 105–119.
38. Müller, M.B., Zimmermann, S., Sillaber, I., Hagemeyer, T.P., Deussing, J.M., Timpl, P., Kormann, M.S.D., Droste, S.K., Kühn, R., Reul, J.M.H.M., Holsboer, F., Wurst, W., Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 6 (2003), 1100–1107, 10.1038/nn1123.
39. Muntingh, A.D.T., van der Feltz-Cornelis, C.M., van Marwijk, H.W.J., Spinhoven, P., Penninx, B.W.J.H., van Balkom, A.J.L.M., Is the Beck Anxiety Inventory a good tool to assess the severity of anxiety? A primary care study in the Netherlands Study of Depression and Anxiety (NESDA). BMC Fam. Pract., 12, 2011, 66, 10.1186/1471-2296-12-66.
40. Parham, K.L., Zervou, S., Karteris, E., Catalano, R.D., Old, R.W., Hillhouse, E.W., Promoter analysis of human Corticotropin-Releasing Factor (CRF) type 1 receptor and regulation by CRF and urocortin. Endocinology 145 (2004), 3971–3983, 10.1210/en.2004-0194.
41. Polymeropoulos, M.H., Torres, R., Yanovski, J.A., Chandrasekharappa, S.C., Ledbetter, D.H., The human Corticotropin-Releasing Factor Receptor (CRHR) gene maps to chromosome 17q12–q22. Genomics., 1995, 10.1006/geno.1995.1118.
42. Provençal, N., Suderman, M.J., Guillemin, C., Massart, R., Ruggiero, A., Wang, D., Bennett, A.J., Pierre, P.J., Friedman, D.P., Côté, S.M., Hallett, M., Tremblay, R.E., Suomi, S.J., Szyf, M., The signature of maternal rearing in the methylome in rhesus macaque prefrontal cortex and T cells. J. Neurosci. 32 (2012), 15626–15642, 10.1523/JNEUROSCI.1470-12.2012.
43. Refojo, D., Schweizer, M., Kuehne, C., Ehrenberg, S., Thoeringer, C., Vogl, A.M., Dedic, N., Schumacher, M., von Wolff, G., Avrabos, C., Touma, C., Engblom, D., Schütz, G., Nave, K.-A., Eder, M., Wotjak, C.T., Sillaber, I., Holsboer, F., Wurst, W., Deussing, J.M., Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 333 (2011), 1903–1907, 10.1126/science.1202107.
44. Risbrough, V.B., Stein, M.B., Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm. Behav. 50 (2006), 550–561, 10.1016/j.yhbeh.2006.06.019.
45. Roberts, S., Lester, K.J., Hudson, J.L., Rapee, R.M., Creswell, C., Cooper, P.J., Thirlwall, K.J., Coleman, J.R.I., Breen, G., Wong, C.C.Y., Eley, T.C., Serotonin transporter [corrected] methylation and response to cognitive behaviour therapy in children with anxiety disorders. Transl. Psychiatry, 4, 2014, e444, 10.1038/tp.2014.83.
46. Rogers, J., Raveendran, M., Fawcett, G.L., Fox, A.S., Shelton, S.E., Oler, J.A., Cheverud, J., Muzny, D.M., Gibbs, R.A., Davidson, R.J., Kalin, N.H., CRHR1 genotypes, neural circuits and the diathesis for anxiety and depression. Mol. Psychiatry 18 (2013), 700–707, 10.1038/mp.2012.152.
47. Sabariego, M., Morón, I., Gómez, M.J., Donaire, R., Tobeña, A., Fernández-Teruel, A., Martínez-Conejero, J.A., Esteban, F.J., Torres, C., Incentive loss and hippocampal gene expression in inbred Roman high- (RHA-I) and Roman low- (RLA-I) avoidance rats. Behav. Brain Res. 257 (2013), 62–70, 10.1016/j.bbr.2013.09.025.
48. Salim, S., Hite, B., Eikenburg, D.C., Activation of the CRF 1 receptor causes ERK1/2 mediated increase in GRK3 expression in CATH. a cells. FEBS Lett. 581 (2007), 3204–3210, 10.1016/j.febslet.2007.06.006.
49. Schreiber, W., Lauer, C.J., Krumrey, K., Holsboer, F., Krieg, J.C., Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder. Neuropsychopharmacology 15 (1996), 7–15, 10.1016/0893-133X(95)00146-5.
50. Schuster, R., Kleimann, A., Rehme, M.-K., Taschner, L., Glahn, A., Groh, A., Frieling, H., Lichtinghagen, R., Hillemacher, T., Bleich, S., Heberlein, A., Elevated methylation and decreased serum concentrations of BDNF in patients in levomethadone compared to diamorphine maintenance treatment. Eur. Arch. Psychiatry Clin. Neurosci., 2016, 1–8, 10.1007/s00406-016-0668-7.
51. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, G.C., The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59:Suppl 2 (1998), 22–33 (quiz 34–57).
52. Shumay, E., Logan, J., Volkow, N.D., Fowler, J.S., Evidence that the methylation state of the monoamine oxidase A (MAOA) gene predicts brain activity of MAO A enzyme in healthy men. Epigenetics 7 (2012), 1151–1160, 10.4161/epi.21976.
53. Smith, S.M., Vale, W.W., The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialog-. Clin. Neurosci. 8 (2006), 383–395.
54. Sotnikov, S.V., Markt, P.O., Malik, V., Chekmareva, N.Y., Naik, R.R., Sah, A., Singewald, N., Holsboer, F., Czibere, L., Landgraf, R., Bidirectional rescue of extreme genetic predispositions to anxiety: impact of CRH receptor 1 as epigenetic plasticity gene in the amygdala. Transl. Psychiatry, 4, 2014, e359, 10.1038/tp.2013.127.
55. Steer, R.A., Beck, A.T., 1990. Beck Anxiety Inventory.
56. Suzuki, M.M., Bird, A., DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9 (2008), 465–476, 10.1038/nrg2341.
57. Sztainberg, Y., Kuperman, Y., Tsoory, M., Lebow, M., Chen, A., The anxiolytic effect of environmental enrichment is mediated via amygdalar CRF receptor type 1. Mol. Psychiatry 15 (2010), 905–917, 10.1038/mp.2009.151.
58. Tadić, A., Müller-Engling, L., Schlicht, K.F., Kotsiari, A., Dreimüller, N., Kleimann, A., Bleich, S., Lieb, K., Frieling, H., Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol. Psychiatry 19 (2014), 281–283, 10.1038/mp.2013.58.
59. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J.M., Stalla, G.K., Blanquet, V., Steckler, T., Holsboer, F., Wurst, W., Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19 (1998), 162–166, 10.1038/520.
60. Todkar, A., Granholm, L., Aljumah, M., Nilsson, K.W., Comasco, E., Nylander, I., HPA axis gene expression and DNA methylation profiles in rats exposed to early life stress, adult voluntary ethanol drinking and single housing. Front. Mol. Neurosci., 8, 2016, 90, 10.3389/fnmol.2015.00090.
61. Tyrka, A.R., Price, L.H., Gelernter, J., Schepker, C., Anderson, G.M., Carpenter, L.L., Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biol. Psychiatry 66 (2009), 681–685, 10.1016/j.biopsych.2009.05.012.
62. Unternaehrer, E., Meyer, A.H., Burkhardt, S.C.A., Dempster, E., Staehli, S., Theill, N., Lieb, R., Meinlschmidt, G., Childhood maternal care is associated with DNA methylation of the genes for brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) in peripheral blood cells in adult men and women. Stress 18 (2015), 451–461, 10.3109/10253890.2015.1038992.
63. Ursini, G., Bollati, V., Fazio, L., Porcelli, A., Iacovelli, L., Catalani, A., Sinibaldi, L., Gelao, B., Romano, R., Rampino, A., Taurisano, P., Mancini, M., Di Giorgio, A., Popolizio, T., Baccarelli, A., De Blasi, A., Blasi, G., Bertolino, A., Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J. Neurosci. 31 (2011), 6692–6698, 10.1523/JNEUROSCI.6631-10.2011.
64. Valentino, R.J., Foote, S.L., Aston-Jones, G., Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res. 270 (1983), 363–367.
65. Wang, X., Meng, F.-S., Liu, Z.-Y., Fan, J.-M., Hao, K., Chen, X.-Q., Du, J.-Z., Gestational hypoxia induces sex-differential methylation of Crhr1 linked to anxiety-like behavior. Mol. Neurobiol. 48 (2013), 544–555, 10.1007/s12035-013-8444-4.
66. Wang, X.-D., Labermaier, C., Holsboer, F., Wurst, W., Deussing, J.M., Müller, M.B., Schmidt, M.V., Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain corticotropin-releasing hormone receptor 1. Eur. J. Neurosci. 36 (2012), 2360–2367, 10.1111/j.1460-9568.2012.08148.x.
67. Weber, H., Richter, J., Straube, B., Lueken, U., Domschke, K., Schartner, C., Klauke, B., Baumann, C., Pané-Farré, C., Jacob, C.P.P., Scholz, C.-J.C.-J., Zwanzger, P., Lang, T., Fehm, L., Jansen, A., Konrad, C., Fydrich, T., Wittmann, A., Pfleiderer, B., Ströhle, A., Gerlach, A.L.L., Alpers, G.W.W., Arolt, V., Pauli, P., Wittchen, H.-U.H.-U., Kent, L., Hamm, A., Kircher, T., Deckert, J., Reif, A., Baumann, C., Pané-Farré, C., Jacob, C.P.P., Scholz, C.-J.C.-J., Zwanzger, P., Lang, T., Fehm, L., Jansen, A., Konrad, C., Fydrich, T., Wittmann, A., Pfleiderer, B., Ströhle, A., Gerlach, A.L.L., Alpers, G.W.W., Arolt, V., Pauli, P., Wittchen, H.-U.H.-U., Kent, L., Hamm, A., Kircher, T., Deckert, J., Reif, A., Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing. Mol. Psychiatry, 21, 2015, 10.1038/mp.2015.125.
68. White, S., Acierno, R., Ruggiero, K.J., Koenen, K.C., Kilpatrick, D.G., Galea, S., Gelernter, J., Williamson, V., McMichael, O., Vladimirov, V.I., Amstadter, A.B., Association of CRHR1 variants and posttraumatic stress symptoms in hurricane exposed adults. J. Anxiety Disord. 27 (2013), 678–683, 10.1016/j.janxdis.2013.08.003.
69. Wittchen, H.-U., Zaudig, M., Fydrich, T., 1997. Strukturiertes Klinisches Interview für DSM-IV.
70. Ziegler, C., Dannlowski, U., Bräuer, D., Stevens, S., Laeger, I., Wittmann, H., Kugel, H., Dobel, C., Hurlemann, R., Reif, A., Lesch, K.-P., Heindel, W., Kirschbaum, C., Arolt, V., Gerlach, A.L., Hoyer, J., Deckert, J., Zwanzger, P., Domschke, K., Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety. Neuropsychopharmacology 40 (2015), 1528–1538, 10.1038/npp.2015.2.
71. Ziegler, C., Richter, J., Mahr, M., Gajewska, A., Schiele, M.A., Gehrmann, A., Schmidt, B., Lesch, K.-P., Lang, T., Helbig-Lang, S., Pauli, P., Kircher, T., Reif, A., Rief, W., Vossbeck-Elsebusch, A.N., Arolt, V., Wittchen, H.-U., Hamm, A.O., Deckert, J., Domschke, K., MAOA gene hypomethylation in panic disorder – reversibility of an epigenetic risk pattern by psychotherapy. Transl. Psychiatry, 2016, e773, 10.1038/tp.2016.41.
72. Zocco, D., McMorrow, J.P., Murphy, E.P., Histamine modulation of peripheral CRH receptor type 1α expression is dependent on Ca2+ signalling and NF-κB/p65 transcriptional activity. Mol. Immunol. 47 (2010), 1426–1437, 10.1016/j.molimm.2010.02.012.